icosapent ethyl,amr101
amarin pharma
['reduce-it', 'icosapent', 'vascepa']
amarin announces new reduce-it(r) data at acc.23/wcc showing benefit of vascepa(r)/vazkepa(r) (icosapent ethyl) in high-risk patients with a recent acute coronary syndrome event 
We provide a balanced view on small cap biotech equities.